Rotenone as a Mitochondrial Metabolism Modulator in Disease Research

Introduction: Beyond Inhibition—Rotenone as a Window into Mitochondrial Metabolism

Mitochondrial dysfunction is a central hallmark of numerous neurodegenerative diseases, metabolic disorders, and age-related cellular decline. The ability to induce, dissect, and modulate this dysfunction is pivotal for advancing both basic and translational research. Rotenone (CAS 83-79-4), a potent mitochondrial Complex I inhibitor, has become indispensable not only as a tool for inducing mitochondrial dysfunction but also as a probe for unraveling the intricate network of metabolic regulation, proteostasis, and signaling pathways in cells and animal models.

While prior reviews such as "Rotenone: Advanced Insights into Mitochondrial Dysfunction" have thoroughly outlined rotenone’s role in classical mitochondrial impairment and proteostasis, this article uniquely emphasizes its utility as a modulator of mitochondrial metabolism and a catalyst for investigating the post-translational control of metabolic enzymes. Incorporating insights from the latest mechanistic research (Wang et al., 2025), we explore how rotenone enables the study of metabolic flux, enzyme regulation, and ROS-driven cellular signaling beyond mere Complex I inhibition.

Mechanism of Action: Rotenone as a Mitochondrial Complex I Inhibitor

Biochemical Targeting of Electron Transport

Rotenone acts as a highly selective inhibitor of mitochondrial Complex I (NADH:ubiquinone oxidoreductase), with an IC₅₀ of 1.7–2.2 μM. By binding to the ubiquinone binding site of Complex I, rotenone blocks electron transfer from NADH to ubiquinone, suppressing the mitochondrial proton gradient and disrupting oxidative phosphorylation. This leads to a marked decrease in ATP production and the accumulation of upstream electron carriers.

ROS Generation and Mitochondrial Dysfunction

The blockade of electron flow results in increased electron leakage and the formation of reactive oxygen species (ROS), particularly superoxide anions. Elevated ROS act as signaling molecules but, in excess, cause oxidative damage to mitochondrial and cellular components, triggering apoptosis and activating stress-responsive pathways.

Rotenone as a Mitochondrial Dysfunction Inducer: Insights from Proteostasis and Metabolic Regulation

Post-Translational Control of Key Metabolic Enzymes

Recent advances have revealed that mitochondrial metabolism is not solely dictated by substrate availability or transcriptional control but also by post-translational regulation of enzyme levels. The mitochondrial DNAJC co-chaperone TCAIM, as described by Wang et al. (2025), specifically binds to the α-ketoglutarate dehydrogenase (OGDH) complex, promoting its degradation through interactions with HSPA9 and LONP1. This process reduces OGDH complex activity, slows the TCA cycle, and shifts cellular metabolism toward alternative pathways such as reductive carboxylation and HIF-1α stabilization.

In this context, rotenone serves as a powerful tool to interrogate the interplay between electron transport inhibition, ROS generation, and the adaptive regulation of mitochondrial enzymes and proteostasis. Its ability to induce mitochondrial dysfunction creates a controlled environment for studying how cells compensate via post-translational adjustments of metabolic enzymes, as highlighted by the TCAIM–OGDH axis.

Distinctive Focus: From Electron Transport Blockade to Enzyme Regulation

While articles like "Rotenone as a Precision Probe: Unraveling Complex I Dysfunction" center on rotenone’s utility for mapping electron transport and broad metabolic effects, this article uniquely extends the discussion to the post-translational tuning of key TCA cycle enzymes and the emerging role of mitochondrial proteostasis in disease models.

Experimental Applications: Apoptosis, Autophagy, and Signaling Pathways

Apoptosis Inducer in SH-SY5Y Cells

Rotenone is widely utilized for inducing apoptosis in differentiated SH-SY5Y neuroblastoma cells. At nanomolar concentrations (e.g., 50 nM), rotenone initiates a biphasic survival response characterized by early mitochondrial depolarization, ROS production, and caspase cascade activation. This makes it an ideal agent for caspase activation assays and for dissecting the molecular sequence leading from mitochondrial impairment to programmed cell death.

Autophagy Pathway Research

Disruption of oxidative phosphorylation by rotenone triggers compensatory autophagy. Researchers can leverage this effect to study autophagy initiation, lysosomal flux, and the cross-talk between mitochondrial stress and cellular recycling pathways. This is particularly relevant in the context of neurodegenerative disease research, where defective mitophagy contributes to the accumulation of dysfunctional mitochondria.

ROS-Mediated Cell Death and Stress-Responsive Signaling

Rotenone-induced ROS not only drive cell death but also activate stress-responsive MAP kinase pathways, including p38 MAPK and JNK signaling. These pathways orchestrate cellular adaptation, inflammation, and, in some contexts, survival. By titrating rotenone exposure, researchers can finely map the threshold between adaptive signaling and cytotoxicity, a nuance often overlooked in more generalized reviews such as "Rotenone: Probing Mitochondrial Complex I and Metabolic Regulation".

Comparative Analysis: Rotenone versus Alternative Mitochondrial Dysfunction Tools

Multiple agents can induce mitochondrial dysfunction, including antimycin A (Complex III inhibitor), oligomycin (ATP synthase inhibitor), and FCCP (uncoupler). However, Rotenone remains uniquely positioned for several reasons:

• Specificity: Rotenone’s high affinity for Complex I allows precise modulation of NADH oxidation without confounding effects on downstream complexes.
• Reproducibility: Its well-characterized kinetics and dose–response relationships enable standardized protocols across cell and animal models.
• Integration with Modern Proteostasis Studies: Only rotenone robustly recapitulates the redox and metabolic imbalances required to study enzyme-level regulation, such as the TCAIM–OGDH pathway, in physiologically relevant contexts.

Although "Rotenone as a Mitochondrial Dysfunction Tool: Insights for Proteostatic Control" discusses the intersection of rotenone with OGDH regulation and proteostasis, the present article delves deeper into the mechanistic interface between rotenone-induced dysfunction and post-translational enzyme downregulation, offering a more focused analysis of metabolic modulation.

Advanced Applications in Neurodegenerative Disease and Metabolic Research

Parkinson’s Disease and Dopaminergic Neurite Degeneration

Rotenone’s ability to mimic the biochemical and phenotypic hallmarks of Parkinson’s disease has made it a gold-standard agent for animal modeling. Intranasal administration of rotenone leads to selective degeneration of dopaminergic neurites in the substantia nigra and impairs olfactory function, closely recapitulating early-stage Parkinsonian pathology.

Neurodegenerative Disease Research Beyond Parkinson’s

The study of mitochondrial dysfunction and proteostasis using rotenone is not limited to Parkinson’s models. By modulating metabolic enzymes and ROS-dependent pathways, rotenone facilitates the exploration of mechanisms underlying Alzheimer’s, Huntington’s, and amyotrophic lateral sclerosis (ALS), where mitochondrial metabolism and proteostasis are disrupted.

Dissecting Metabolic Plasticity and Adaptive Signaling

Thanks to its robust induction of mitochondrial stress, rotenone enables fine-grained analysis of how cells rewire their metabolism in response to energetic deficits. This includes the upregulation of glycolysis, stabilization of HIF-1α, and the engagement of alternative biosynthetic pathways. The findings of Wang et al. (2025) on the TCAIM-mediated downregulation of OGDH further illustrate the importance of post-translational control in this adaptive response, and rotenone-induced models are ideally suited for probing these dynamics in vitro and in vivo.

Practical Considerations for Rotenone Use in Research

Solubility, Storage, and Handling

Rotenone is a solid compound, highly insoluble in ethanol and water but readily soluble in DMSO at concentrations ≥77.6 mg/mL. Stock solutions should be prepared fresh, stored below -20°C, and are not recommended for long-term storage once dissolved due to instability. The compound is shipped on blue ice and designated for research use only, not for diagnostic or medical applications.

Optimization of Experimental Design

• Use graded doses to delineate thresholds for ROS generation, apoptosis, and adaptive signaling.
• Pair with assays for caspase activation, autophagy flux, and MAP kinase pathway readouts to capture the breadth of rotenone’s effects.
• Integrate with genetic or pharmacological modulation of proteostasis factors (e.g., TCAIM, HSPA9, LONP1) to dissect post-translational regulatory mechanisms.

Conclusion and Future Outlook: Rotenone at the Forefront of Mitochondrial Research

Rotenone remains an unrivaled tool for inducing controlled mitochondrial dysfunction, enabling researchers to probe the full spectrum of metabolic regulation, proteostasis, and signal transduction. By bridging classical bioenergetics with cutting-edge insights into enzyme-level control, rotenone facilitates the exploration of both disease mechanisms and potential therapeutic interventions. As our understanding of mitochondrial proteostasis and metabolic adaptation deepens, integrating rotenone-based models with genetic and proteomic tools will be key to elucidating novel regulatory axes and developing targeted strategies for neurodegenerative and metabolic diseases.

To further expand your understanding, we recommend consulting "Rotenone as a Mitochondrial Dysfunction Inducer: Insights" for a broader overview of rotenone’s role in cell death and metabolic regulation, noting that the present article offers a more granular focus on metabolic enzyme modulation and post-translational proteostasis—a critical frontier in disease modeling and therapeutic discovery.